A pivotal new study from Queen Mary University of London highlights an alarming trend: around 9% of all reported adverse drug reactions (ADRs) submitted to the UK medicines regulator can be linked to medications whose side effect risks are influenced by a …

… a consumer alert for a gene testing company. The alert comes after …

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Persistence is in Anne Wojcicki’s DNA. The co-founder of 23andMe, an innovative at-home genetic testing service, has watched her …

The British Horseracing Authority (BHA) is expanding its equine anti-doping programme to include testing for evidence of gene doping, following extensive research into detection methods. In a significant move to protect the integrity of British racing and …

23andMe, which provides medical and ancestry-related genetic testing, has filed for bankruptcy after it was unable to find a buyer to rescue it from insolvency proceedings and the board of directors rejected a buyout offer from co-founder Anne Wojcicki. …

(Bloomberg) -- 23andMe Holding Co., which provides medical and ancestry-related genetic testing, filed for bankruptcy after it was unable to find a buyer to rescue it from insolvency proceedings and the board of directors rejected a buyout offer from co- …

Up to 10% of cancers are caused by genes that can be easily detected by commercially available tests. These include such common cancers as cancer of the breast, ovary, colon, stomach, uterus and pancreas.  “We don’t routinely screen for cancer …

… Tags: advancements in oncology geneticscancer gene testing in primary carecancer risk evaluation …

Up to 10% of cancers are caused by genes that can be easily detected by commercially available tests. These include such common cancers as cancer of the breast, ovary, colon, stomach, uterus and pancreas.  “We don’t routinely screen for cancer …

… to create personalised care pathways. Gene testing is also helping predict future …